Email this article 
COMBINATION OF TAXOL WITH CARBOPLATIN IN THE TREATMENT OF PATIENTS WITH STAGES IIB-IV OVARIAN CANCER (FIRST MULTI-CENTER EXPERIENCE IN RUSSIA)
- Authors: Martinova Z.A.1, Poddubnaya I.V.1
-
Affiliations:
- Department of Oncology, Russian Medical Academy for Post-Graduate Education, Moscow
- Issue: No 2 (2008)
- Pages: 70-72
- Section: GYNECOLOGY. TREATMENT
- Published: 16.05.2008
- URL: https://ojrs.abvpress.ru/ojrs/article/view/354
- DOI: https://doi.org/10.17650/1994-4098-2008-0-2-70-72
- ID: 354
Cite item
Full Text
Abstract
Taking into account the fact that the treatment of advanced ovarian cancer includes cytoreductive surgery and chemotherapy, it is important to take advantage of contemporary highly effective agents. In 2003 the Regional program for optimization of ovarian cancer treatment in Cancer centers of Russia was initiated: 100 patients from 22 Cancer dispensaries received combination chemotherapy with Taxol at the dose of 175 mg/m2 as 3 hours intravenous infusion, then Carboplatin at the dose to obtain AUC=5,0 (TCb scheme). As a result of this multi-center study, the effectiveness of TCb scheme as first line chemotherapy was confirmed. The scheme can be successfully implemented in Cancer Centers.
About the authors
Zh. A. Martinova
Department of Oncology, Russian Medical Academy for Post-Graduate Education, Moscow
Author for correspondence.
Russian Federation
I. V. Poddubnaya
Department of Oncology, Russian Medical Academy for Post-Graduate Education, MoscowRussian Federation
References
Supplementary files
